Rapport Therapeutics Inc (NAS:RAPP)
$ 41.96 -0.19 (-0.45%) Market Cap: 2.01 Bil Enterprise Value: 1.54 Bil PE Ratio: 0 PB Ratio: 4.26 GF Score: 14/100

Rapport Therapeutics Inc at TD Cowen Healthcare Conference Transcript

Mar 3, 2026 / 08:10 PM GMT
Release Date Price: $27.85 (-1.83%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RAPP.OQ - Rapport Therapeutics Inc
Rapport Therapeutics Inc at TD Cowen Healthcare Conference
Mar 03, 2026 / 08:10PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
I think we're going to go ahead and get started.

Thank you everyone for joining us on day two in the room and online for the 2026 46th annual TD Cowan Healthcare Conference. I'm Joe Thol I'm one of the senior biotech analysts here on the team at TD Cowan, and it is my pleasure to have with me today the management team from Rapport Therapeutics.

And with me today we have Abe CIA who's the CEO, and joining us in a moment will be Troygnelli. CFO, so maybe we'll just kick things off before we dive into the individual programs, but obviously a lot of progress over the past 12 months. So if you want to kind of hit the highlights of, the big things that happened in 2025 and early 20,206 and what
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot